Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

May 01, 1999; Volume 289,Issue 2

Articles

  • You have access
    Regulation of Opioid Receptor Activities
    Ping-Yee Law and Horace H. Loh
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 607-624;
  • You have access
    Insulinotropic Effect of New Glibenclamide Isosteres
    R. Ouedraogo, Q.-A. Nguyen, M.-H. Antoine, C. Kane, M.J. Dunne, L. Pochet, B. Masereel and P. Lebrun
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 625-631;
  • You have access
    Differential Induction of Nitric Oxide Synthase in Rat Gastric and Vascular Smooth Muscle Tissue: Distinct Tissue Distribution and Distinctive Signaling Pathways
    Xi-Long Zheng, Yu Gui, Keith A. Sharkey and Morley D. Hollenberg
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 632-640;
  • You have access
    Cytochrome P-450-Dependent Bioactivation of 1,1-Dichloroethylene to a Reactive Epoxide in Human Lung and Liver Microsomes
    Taylor F. Dowsley, Ken Reid, Dimitri Petsikas, Judith B. Ulreich, Robyn L. Fisher and Poh-Gek Forkert
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 641-648;
  • You have access
    Interleukin-2 Overexpresses c-myc and Down-Regulates Cytochrome P-450 in Rat Hepatocytes
    Marina Tinel, Johny Elkahwaji, Marie Anne Robin, Nicolas Fardel, Veronique Descatoire, Delphine Haouzi, Alain Berson and Dominique Pessayre
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 649-655;
  • You have access
    Dependence of Nicotinic Acetylcholine Receptor Recovery from Desensitization on the Duration of Agonist Exposure
    Raven Reitstetter, Ronald J. Lukas and Raphael Gruener
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 656-660;
  • You have access
    Competition Between Cytochrome P-450 Isozymes for NADPH-Cytochrome P-450 Oxidoreductase Affects Drug Metabolism
    Dongtao N. Li, Michael P. Pritchard, Steven P. Hanlon, Brian Burchell, C. Roland Wolf and Thomas Friedberg
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 661-667;
  • You have access
    Combination of Hypoxia/Aglycemia Compromises In Vitro Blood-Brain Barrier Integrity
    Thomas J. Abbruscato and Thomas P. Davis
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 668-675;
  • You have access
    Hydrolytic Activity Is Essential for Aceclofenac To Inhibit Cyclooxygenase in Rheumatoid Synovial Cells
    Ryuta Yamazaki, Shinichi Kawai, Tsuneo Matsumoto, Takeshi Matsuzaki, Shusuke Hashimoto, Teruo Yokokura, Renzo Okamoto, Tomihisa Koshino and Yutaka Mizushima
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 676-681;
  • You have access
    Characterization of Vagal Afferent Subtypes Stimulated by Bradykinin in Guinea Pig Trachea
    Radhika Kajekar, David Proud, Allen C. Myers, Sonya N. Meeker and Bradley J. Undem
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 682-687;
  • You have access
    Clonidine Evokes Vasodepressor Responses via α2-Adrenergic Receptors in Gigantocellular Reticular Formation
    Sue A. Aicher and Carrie T. Drake
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 688-694;
  • You have access
    Inhibition of Isoniazid-Induced Hepatotoxicity in Rabbits by Pretreatment with an Amidase Inhibitor ,
    Troy C. Sarich, Stephen P. Adams, Giorgio Petricca and James M. Wright
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 695-702;
  • You have access
    Anticonvulsant Efficacy ofN-Methyl-d-Aspartate Antagonists Against Convulsions Induced by Cocaine
    Jeffrey M. Witkin, Maciej Gasior, Boris Heifets and Frank C. Tortella
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 703-711;
  • You have access
    Cardiopulmonary Effects of the α2-Adrenoceptor Agonists Medetomidine and ST-91 in Anesthetized Sheep
    C. S. Celly, W. N. McDonell and W. D. Black
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 712-720;
  • You have access
    The Phospholipase C Inhibitor U73122 Inhibits Phorbol Ester-Induced Platelet Activation
    Leslie K. Lockhart and Archibald McNicol
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 721-728;
  • You have access
    Inhibition of Gastric Emptying by Triterpene Saponin, Momordin Ic, in Mice: Roles of Blood Glucose, Capsaicin-Sensitive Sensory Nerves, and Central Nervous System
    H. Matsuda, Y. Li, J. Yamahara and M. Yoshikawa
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 729-734;
  • You have access
    Effects of Specific Inhibition of Cyclooxygenase-2 on Sodium Balance, Hemodynamics, and Vasoactive Eicosanoids
    Francesca Catella-Lawson, Brendan McAdam, Briggs W. Morrison, Shiv Kapoor, Dean Kujubu, Lisa Antes, Kenneth C. Lasseter, Hui Quan, Barry J. Gertz and Garret A. Fitzgerald
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 735-741;
  • You have access
    SR146131: A New Potent, Orally Active, and Selective Nonpeptide Cholecystokinin Subtype 1 Receptor Agonist. I: In Vitro Studies
    Eric Bignon, André Bachy, Robert Boigegrain, Roger Brodin, Michèle Cottineau, Danielle Gully, Jean-Marc Herbert, Peter Keane, Christophe Labie, Jean-Charles Molimard, Dominique Olliero, Florence Oury-Donat, Christophe Petereau, Valérie Prabonnaud, Marie-Pierre Rockstroh, Paul Schaeffer, Orlane Servant, Olivier Thurneyssen, Philippe Soubrié, Marc Pascal, Jean-Pierre Maffrand and Gérard Le Fur
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 742-751;
  • You have access
    SR146131: A New Potent, Orally Active, and Selective Nonpeptide Cholecystokinin Subtype 1 Receptor Agonist. II: In Vivo Pharmacological Characterization
    Eric Bignon, Richard Alonso, Michèle Arnone, Robert Boigegrain, Roger Brodin, Christiane Gueudet, Michel Héaulme, Peter Keane, Marco Landi, Jean-Charles Molimard, Dominique Olliero, Martine Poncelet, Eric Seban, Jacques Simiand, Philippe Soubrié, Marc Pascal, Jean-Pierre Maffrand and Gérard Le Fur
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 752-761;
  • You have access
    Mechanisms of Endothelin-Induced Venoconstriction in Isolated Guinea Pig Mesentery
    Ron J. Johnson, Gregory D. Fink and James J. Galligan
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 762-767;
  • You have access
    Novel Membrane Transporter OCTN1 Mediates Multispecific, Bidirectional, and pH-Dependent Transport of Organic Cations
    Hikaru Yabuuchi, Ikumi Tamai, Jun-Ichi Nezu, Kazuki Sakamoto, Asuka Oku, Miyuki Shimane, Yoshimichi Sai and Akira Tsuji
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 768-773;
  • You have access
    Effects of Ethanol on Recombinant Human Neuronal Nicotinic Acetylcholine Receptors Expressed in XenopusOocytes
    Rita A. Cardoso, Susan J. Brozowski, Laura E. Chavez-Noriega, Michael Harpold, C. Fernando Valenzuela and R. Adron Harris
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 774-780;
  • You have access
    Proteasome Inhibition Leads to Significant Reduction of Bcr-Abl Expression and Subsequent Induction of Apoptosis in K562 Human Chronic Myelogenous Leukemia Cells
    Q. Ping Dou, Terence F. McGuire, Yibing Peng and Bing An
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 781-790;
  • You have access
    Effects of Luteinizing Hormone-Releasing Hormone on Plasma Cocaine Levels in Rhesus Monkeys
    Jack H. Mendelson, Nancy K. Mello and S. Stevens Negus
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 791-799;
  • You have access
    Evaluation of Individual and Combined Neurotoxicity of the Immunosuppressants Cyclosporine and Sirolimus by In Vitro Multinuclear NMR Spectroscopy
    Natalie Serkova, Lawrence Litt, Thomas L. James, Wolfgang Sadée, Dieter Leibfritz, Leslie Z. Benet and Uwe Christians
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 800-806;
  • You have access
    Liposomal Lipid and Plasmid DNA Delivery to B16/BL6 Tumors after Intraperitoneal Administration of Cationic Liposome DNA Aggregates
    Dorothy L. Reimer, Spencer Kong, Myrna Monck, Jessica Wyles, Pat Tam, Ellen K. Wasan and Marcel B. Bally
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 807-815;
  • You have access
    Size of Lipid Microdroplets Effects Results of Hepatic Arterial Chemotherapy with an Anticancer Agent in Water-in-Oil-in-Water Emulsion to Hepatocellular Carcinoma
    Shushi Higashi, Naoto Tabata, Kazu-Hiro Kondo, Yorio Maeda, Masataka Shimizu, Tadao Nakashima and Toshiaki Setoguchi
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 816-819;
  • You have access
    Inhibition and Stimulation of Long-Chain Fatty Acid Oxidation by Chloroacetaldehyde and Methylene Blue in Rats
    Theresa M. Visarius, Jörg W. Stucki and Bernhard H. Lauterburg
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 820-824;
  • You have access
    Differences in Cadmium Transport to the Testis, Epididymis, and Brain in Cadmium-Sensitive and -Resistant Murine Strains 129/J and A/J
    Laura M. King, William A. Banks and William J. George
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 825-830;
  • You have access
    Temporal Differences in Actions of Calcium Channel Blockers on K+ Accumulation, Cardiac Function, and High-Energy Phosphate Levels in Ischemic Guinea Pig Hearts
    Ryuichi Sato, Jun Yamazaki and Taku Nagao
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 831-839;
  • You have access
    Spinal Blockade of Opioid Receptors Prevents the Analgesia Produced by TENS in Arthritic Rats
    Kathleen A. Sluka, Merek Deacon, Andrea Stibal, Shannon Strissel and Amy Terpstra
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 840-846;
  • You have access
    Post-Translational Inhibition of Cytochrome P-450 2E1 Expression by Chlomethiazole in Fao Hepatoma Cells
    Anastasia Simi and Magnus Ingelman-Sundberg
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 847-852;
  • You have access
    Inhibition of Human Liver Cytochrome P-450 1A2 by the Class IB Antiarrhythmics Mexiletine, Lidocaine, and Tocainide
    Xiaoxiong Wei, Renke Dai, Suoping Zhai, Kenneth E. Thummel, Fred K. Friedman and Robert E. Vestal
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 853-858;
  • You have access
    Enhancement of μ Opioid Antinociception by Oral Δ9-Tetrahydrocannabinol: Dose-Response Analysis and Receptor Identification
    Diana L. Cichewicz, Zachary L. Martin, Forrest L. Smith and Sandra P. Welch
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 859-867;
  • You have access
    Periaqueductal Gray Stimulation-Induced Inhibition of Nociceptive Dorsal Horn Neurons in Rats Is Associated with the Release of Norepinephrine, Serotonin, and Amino Acids
    M. Cui, Y. Feng, D. J. McAdoo and W. D. Willis
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 868-876;
  • You have access
    Characteristics of Drug Interactions with Recombinant Biogenic Amine Transporters Expressed in the Same Cell Type
    Amy J. Eshleman, Marya Carmolli, Medhane Cumbay, Carey R. Martens, Kim A. Neve and Aaron Janowsky
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 877-885;
  • You have access
    Subtype-Selective Antagonism ofN-Methyl-d-Aspartate Receptors by Felbamate: Insights into the Mechanism of Action
    Nancy W. Kleckner, Jill C. Glazewski, Chi Chiung Chen and Tammy D. Moscrip
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 886-894;
  • You have access
    Glyceryl Trinitrate-Induced Vasodilation Is Inhibited by Ultraviolet Irradiation Despite Enhanced Nitric Oxide Generation: Evidence for Formation of a Nitric Oxide Conjugate
    Aman S. Hussain, Natascha H. Crispino, Brian E. McLaughlin, James F. Brien, Gerald S. Marks and Kanji Nakatsu
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 895-900;
  • You have access
    Osmotic Regulation of Airway Reactivity by Epithelium
    Jeffrey S. Fedan, Long-Xing Yuan, Victoria C. Chang, Joseph O. Viola, Deborah Cutler and Loreen L. Pettit
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 901-910;
  • You have access
    Changes in Smooth Muscle Tone During Osmotic Challenge in Relation to Epithelial Bioelectric Events in Guinea Pig Isolated Trachea
    Juanita Dortch-Carnes, Michael R. van Scott and Jeffrey S. Fedan
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 911-917;
  • You have access
    Adrenoceptors Mediating the Cardiovascular and Metabolic Effects of α-Methylnoradrenaline in Humans
    Rafael F. Schäfers, Jens Nürnberger, Burghard Herrmann, Rene R. Wenzel, Thomas Philipp and Martin C. Michel
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 918-925;
  • You have access
    Receptor Binding, Behavioral, and Electrophysiological Profiles of Nonpeptide Corticotropin-Releasing Factor Subtype 1 Receptor Antagonists CRA1000 and CRA1001
    Shigeru Okuyama, Shigeyuki Chaki, Naoya Kawashima, Yoshiko Suzuki, Shin-Ichi Ogawa, Atsuro Nakazato, Toshihito Kumagai, Taketoshi Okubo and Kazuyuki Tomisawa
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 926-935;
  • You have access
    Relative Potency of levo-α-Acetylmethadol and Methadone in Humans under Acute Dosing Conditions
    Thomas Eissenberg, Maxine L. Stitzer, George E. Bigelow, August R. Buchhalter and Sharon L. Walsh
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 936-945;
  • You have access
    Determination of [35S]Guanosine-5′-O-(3-thio)Triphosphate Binding Mediated by Cholinergic Muscarinic Receptors in Membranes from Chinese Hamster Ovary Cells and Rat Striatum Using an Anti-G Protein Scintillation Proximity Assay
    Neil W. Delapp, Jamie H. McKinzie, Barry D. Sawyer, Amy Vandergriff, Julie Falcone, Don McClure and Christian C. Felder
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 946-955;
  • You have access
    Zinc Modulates Antagonist Interactions with D2-Like Dopamine Receptors through Distinct Molecular Mechanisms
    John A. Schetz, Alice Chu and David R. Sibley
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 956-964;
  • You have access
    Sensitivity to the Discriminative Stimulus and Antinociceptive Effects of μ Opioids: Role of Strain of Rat, Stimulus Intensity, and Intrinsic Efficacy at the μ Opioid Receptor
    Drake Morgan, Charles D. Cook and Mitchell J. Picker
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 965-975;
  • You have access
    Clearance of Human Brain Natriuretic Peptide in Rabbits; Effect of the Kidney, the Natriuretic Peptide Clearance Receptor, and Peptidase Activity
    Ramona Almirez and Andrew A. Protter
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 976-980;
  • You have access
    A Simple Method for Estimation of Agonist Activity at Receptor Subtypes: Comparison of Native and Cloned M3 Muscarinic Receptors in Guinea Pig Ileum and Transfected Cells
    Frederick J. Ehlert, Michael T. Griffin, Gregory W. Sawyer and Regina Bailon
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 981-992;
  • You have access
    Interaction Between Medullary and Spinal δ1 and δ2 Opioid Receptors in the Production of Antinociception in the Rat
    Robert W. Hurley, Theodore S. Grabow, Ronald J. Tallarida and Donna L. Hammond
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 993-999;
  • You have access
    Clozapine, But Not Haloperidol, Prevents the Functional Hyperactivity of N-Methyl-d-Aspartate Receptors in Rat Cortical Neurons Induced by Subchronic Administration of Phencyclidine
    V. L. Arvanov and R. Y. Wang
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1000-1006;
  • You have access
    Secretory Leukocyte Protease Inhibitor Prevents Allergen-Induced Pulmonary Responses in Animal Models of Asthma
    Clifford D. Wright, Andrew M. Havill, Scot C. Middleton, Mohammed A. Kashem, Patrice A. Lee, David J. Dripps, Thomas G. O’Riordan, Michael P. Bevilacqua and William M. Abraham
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1007-1014;
  • You have access
    Cerebrospinal Fluid Bioavailability and Pharmacokinetics of Bupivacaine and Lidocaine after Intrathecal and Epidural Administrations in Rabbits Using Microdialysis
    Rozenn Clement, Jean-Marc Malinovsky, Pascal Le Corre, Gilles Dollo, Francois Chevanne and Roger Le Verge
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1015-1021;
  • You have access
    A Tyrosine Kinase Signaling Pathway, Regulated by Calcium Entry and Dissociated from Tyrosine Phosphorylation of Phospholipase Cγ-1, Is Involved in Inositol Phosphate Production by Activated G Protein-Coupled Receptors in Myometrium
    Bruno Palmier, Monique Vacher, Simone Harbon and Denis Leiber
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1022-1030;
  • You have access
    Characterization of Neuropeptide Y-Induced Feeding in Mice: Do Y1–Y6 Receptor Subtypes Mediate Feeding?
    Smriti Iyengar, Dominic L. Li and Rosa Maria A. Simmons
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1031-1040;
  • You have access
    Characterization of the Effects of Polyamines on [125I]MK-801 Binding to RecombinantN-Methyl-d-Aspartate Receptors
    Terre A. Sharma and Ian J. Reynolds
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1041-1047;
  • You have access
    d-Methadone Blocks Morphine Tolerance andN-Methyl-d-Aspartate-Induced Hyperalgesia
    Antonia M. Davis and Charles E. Inturrisi
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1048-1053;
  • You have access
    Role of Cytochrome P-450 2E1 in Methacrylonitrile Metabolism and Disposition
    Burhan I. Ghanayem, J. Michael Sanders, Brian Chanas, Leo T. Burka and Frank J. Gonzalez
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1054-1059;
  • You have access
    Prolonged Analgesic Effect of Ketamine, anN-Methyl-d-Aspartate Receptor Inhibitor, in Patients with Chronic Pain
    Toril Rabben, Per Skjelbred and Ivar Øye
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1060-1066;
  • You have access
    Characterization of the Pharmacodynamic Interaction between Parent Drug and Active Metabolite In Vivo: Midazolam and α-OH-Midazolam
    B. Tuk, M. F. van Oostenbruggen, V. M. M. Herben, J. W. Mandema and M. Danhof
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1067-1074;
  • You have access
    Structural Analysis of Angiotensin IV Receptor (AT4) from Selected Bovine Tissues
    Jian-Hua Zhang, Jodie M. Hanesworth, Michael F. Sardinia, Jeremiah A. Alt, John W. Wright and Joseph W. Harding
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1075-1083;
  • You have access
    Active Transport of Fentanyl by the Blood-Brain Barrier
    Thomas K. Henthorn, Yang Liu, Mrinal Mahapatro and Ka-yun Ng
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1084-1089;
  • You have access
    Two Pharmacologically Distinct Components of Nicotinic Receptor-Mediated Rubidium Efflux in Mouse Brain Require the β2 Subunit
    Michael J. Marks, Paul Whiteaker, Jennifer Calcaterra, Jerry A. Stitzel, Amy E. Bullock, Sharon R. Grady, Marina R. Picciotto, Jean-Pierre Changeux and Allan C. Collins
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1090-1103;
  • You have access
    Active Lucifer Yellow Secretion in Renal Proximal Tubule: Evidence for Organic Anion Transport System Crossover
    Rosalinde Masereeuw, Miek M. Moons, Barbara H. Toomey, Frans G. M. Russel and David S. Miller
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1104-1111;
  • You have access
    Stimulation of Pregnant Rat Uterine Contraction by the Polychlorinated Biphenyl (PCB) Mixture Aroclor 1242 May Be Mediated by Arachidonic Acid Release through Activation of Phospholipase A2 Enzymes
    Jeehyeon Bae, Marc Peters-Golden and Rita Loch-Caruso
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1112-1120;
  • You have access
    Insulin Differentially Affects Xenobiotic-Enhanced, Cytochrome P-450 (CYP)2E1, CYP2B, CYP3A, and CYP4A Expression in Primary Cultured Rat Hepatocytes
    Kimberley J. Woodcroft and Raymond F. Novak
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1121-1127;
  • You have access
    Reduction of the Cardiotoxicity of Doxorubicin in Rabbits and Dogs by Encapsulation in Long-Circulating, Pegylated Liposomes
    Peter K. Working, Mary S. Newman, Timothy Sullivan and John Yarrington
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1128-1133;
  • You have access
    First-Pass Midazolam Metabolism Catalyzed by 1α,25-Dihydroxy Vitamin D3-Modified Caco-2 Cell Monolayers
    Jeannine M. Fisher, Steven A. Wrighton, Paul B. Watkins, Phyllissa Schmiedlin-Ren, Justina C. Calamia, Danny D. Shen, Kent L. Kunze and Kenneth E. Thummel
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1134-1142;
  • You have access
    Midazolam Metabolism by Modified Caco-2 Monolayers: Effects of Extracellular Protein Binding
    Jeannine M. Fisher, Steven A. Wrighton, Justina C. Calamia, Danny D. Shen, Kent L. Kunze and Kenneth E. Thummel
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1143-1150;
  • You have access
    Identification and Pharmacological Characterization of a Series of New 1H-4-Substituted-Imidazoyl Histamine H3 Receptor Ligands
    Stephen L. Yates, James G. Phillips, Rosilyn Gregory, Gary P. Pawlowski, Leena Fadnis, M. Amin Khan, Syed M. Ali and Clark E. Tedford
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1151-1159;
  • You have access
    Development oftrans-2-[1H-Imidazol-4-yl] Cyclopropane Derivatives as New High-Affinity Histamine H3 Receptor Ligands
    Clark E. Tedford, James G. Phillips, Rosilyn Gregory, Gary P. Pawlowski, Leena Fadnis, M. Amin Khan, Syed M. Ali, Michael K. Handley and Stephen L. Yates
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1160-1168;
  • You have access
    Glucuronidation of Drugs by Hepatic Microsomes Derived from Healthy and Cirrhotic Human Livers
    Valerie Furlan, Sylvie Demirdjian, Olivier Bourdon, Jacques Magdalou and Anne-Marie Taburet
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1169-1175;
  • You have access
    Targeted Delivery and Improved Therapeutic Potential of Catalase by Chemical Modification: Combination with Superoxide Dismutase Derivatives
    Yoshiyuki Yabe, Makiya Nishikawa, Ayumi Tamada, Yoshinobu Takakura and Mitsuru Hashida
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1176-1184;

Additions and Corrections

  • You have access
    Correction for vol. 288, p. 1143
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1184;
  • You have access
    Correction for vol. 289, p. 8
    Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1184;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 289 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 289, Issue 2
1 May 1999
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Articles
  • Additions and Corrections
  • Most Read
Loading
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • Nose-to-Brain Delivery
  • Interaction between Bupropion and MDMA
  • Smoking Could Worsen COVID-19 Outcome
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics